Shares of ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report) passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.01 and traded as low as $0.0065. ProtoKinetix shares last traded at $0.0075, with a volume of 764,800 shares.
ProtoKinetix Price Performance
The firm’s 50 day moving average price is $0.01 and its 200-day moving average price is $0.01.
About ProtoKinetix
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc and changed its name to ProtoKinetix, Incorporated in July 2003.
Further Reading
- Five stocks we like better than ProtoKinetix
- America’s Next Power Move Starts Underground
- Your Signature Is Missing – Act Before It’s Too Late
- NEW LAW: Congress Approves Setup For Digital Dollar?
- BSEM: A $25.50 Price Target, and Nasdaq on the Horizon!
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
Receive News & Ratings for ProtoKinetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProtoKinetix and related companies with MarketBeat.com's FREE daily email newsletter.
